Autoimmunity: Effectiveness of treatments for pregnant women with APS

Nature Reviews Rheumatology

Volumn 6, Issue 4, 2010, Pages 187-189

  Gelber, Shari E ^a   Salmon, Jane E ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; DIETHYLSTILBESTROL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY;

ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; CLINICAL EFFECTIVENESS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; LIVE BIRTH; LOW DRUG DOSE; MONOTHERAPY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; RECURRENT DISEASE; SHORT SURVEY; SPONTANEOUS ABORTION; TREATMENT RESPONSE;

ABORTION, HABITUAL; ADULT; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; AUTOANTIBODIES; AUTOIMMUNITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 77950597982     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.42     Document Type: Short Survey

References (9)

1. Mak, A., Cheung, M. W., Cheak, A. A. & Ho, R. C. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxford) 49, 281-288 (2010).
2. Levine, J. s., Branch, D. w. &Rauch, J. The antiphospholipid syndrome. N. Engl. J. Med. 346, 752-763 (2002) (Pubitemid 34983997)
3. Empson, M., Lassere, M., Craig, J. & Scott, J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews. issue 2. Art. no.: CD002859. doi:10.1002/14651858. CD002859.pub2 (2005).
4. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. number 24, February 2001. (Replaces Technical Bulletin number 212, september 1995). Int. J. Gynaecol. Obstet. 78, 179-190 (2002)
5. Miyakis, S. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4, 295-306 (2006)
6. Bates, s. M., Greer, i. A., Pabinger, i., sofaer, s. &Hirsh, J. venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-Based Clinical Practice Guidelines (8th edition). Chest 133 (suppl.), s844-s886 (2008) (Pubitemid 351892978)
7. Girardi, G., Redecha, P. &salmon, J. e. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat. Med. 10, 1222-1226 (2004) (Pubitemid 39540439)
8. White, N. J., McGready, R. M. & Nosten, F. H. new medicines for tropical diseases in pregnancy: catch-22. PLoS Med. 5, e133 (2008).
9. Chervenak, F. A. & McCullough, L. B. Ethics of research in perinatal medicine. Semin. Perinatol. 33, 391-396 (2009).